Published in J Cardiovasc Magn Reson on September 22, 2016
Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med (2004) 6.27
Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging (2013) 3.53
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson (2013) 3.52
Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J Cardiovasc Magn Reson (2011) 2.96
T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson (2014) 2.48
T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging (2013) 2.47
Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation (2012) 2.41
Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. JACC Cardiovasc Imaging (2014) 2.41
Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J (2013) 2.21
Effect of Gd-DTPA-BMA on blood and myocardial T1 at 1.5T and 3T in humans. J Magn Reson Imaging (2006) 1.78
Saturation recovery single-shot acquisition (SASHA) for myocardial T(1) mapping. Magn Reson Med (2013) 1.69
T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study. Circ Cardiovasc Imaging (2015) 1.64
Native T1 Mapping by 3-T CMR Imaging for Characterization of Chronic Myocardial Infarctions. JACC Cardiovasc Imaging (2015) 1.56
Adenosine Stress and Rest T1 Mapping Can Differentiate Between Ischemic, Infarcted, Remote, and Normal Myocardium Without the Need for Gadolinium Contrast Agents. JACC Cardiovasc Imaging (2015) 1.54
Modified Look-Locker T1 evaluation using Bloch simulations: human and phantom validation. Magn Reson Med (2012) 1.48
Agarose as a tissue equivalent phantom material for NMR imaging. Magn Reson Imaging (1986) 1.34
An MRI phantom material for quantitative relaxometry. Magn Reson Med (1987) 1.17
Standardization of T1 measurements with MOLLI in differentiation between health and disease--the ConSept study. J Cardiovasc Magn Reson (2013) 1.07
New polyvinyl alcohol gel material for MRI phantoms. Magn Reson Med (1986) 1.00
Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2014) 0.97
Relaxation of solvent protons by solute Gd3+-chelates revisited. Magn Reson Med (1997) 0.88
Ni-DTPA doped agarose gel--a phantom material for Gd-DTPA enhancement measurements. Magn Reson Imaging (1993) 0.86
T1 at 1.5T and 3T compared with conventional T2* at 1.5T for cardiac siderosis. J Cardiovasc Magn Reson (2015) 0.82
Death following exposure to fine particulate nickel from a metal arc process. Ann Occup Hyg (1994) 0.81
Gibbs-ringing artifact removal based on local subvoxel-shifts. Magn Reson Med (2015) 0.81